KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Encompass Health (EHC) Accumulated Depreciation & Amortization (2016 - 2025)

Encompass Health (EHC) has disclosed Accumulated Depreciation & Amortization for 17 consecutive years, with -$3.8 billion as the latest value for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 320.51% year-over-year to -$3.8 billion; the TTM value through Dec 2025 reached -$3.8 billion, down 320.51%, while the annual FY2025 figure was -$3.8 billion, 320.51% down from the prior year.
  • Accumulated Depreciation & Amortization hit -$3.8 billion in Q4 2025 for Encompass Health, down from $1.7 billion in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $1.7 billion in Q4 2024 and bottomed at -$3.8 billion in Q4 2025.
  • Average Accumulated Depreciation & Amortization over 5 years is -$520.6 million, with a median of $1.1 billion recorded in 2021.
  • Year-over-year, Accumulated Depreciation & Amortization soared 168.15% in 2021 and then plummeted 329.57% in 2023.
  • Encompass Health's Accumulated Depreciation & Amortization stood at $1.1 billion in 2021, then increased by 14.3% to $1.3 billion in 2022, then tumbled by 329.57% to -$3.0 billion in 2023, then soared by 157.17% to $1.7 billion in 2024, then tumbled by 320.51% to -$3.8 billion in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at -$3.8 billion, $1.7 billion, and -$3.0 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.